Get the Stockscreener App
1.47
2.00%
-0.03
After Hours:
1.49
0.02
+1.36%
Aptevo Therapeutics Inc stock is traded at $1.47, with a volume of 255.82K.
It is down -2.00% in the last 24 hours and down -28.64% over the past month.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$1.50
Open:
$1.51
24h Volume:
255.82K
Relative Volume:
0.12
Market Cap:
$4.83M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0151
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
-8.70%
1M Performance:
-28.64%
6M Performance:
-96.94%
1Y Performance:
-99.45%
1-Day Range:
$1.43
$1.5424
1-Week Range:
$1.43
$1.60
52-Week Range:
$1.43
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Name
Aptevo Therapeutics Inc
Sector
Industry
Phone
206-838-0500
Address
2401 4TH AVE., SEATTLE, WA
Compare APVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.47 | 4.93M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-05-17 | Resumed | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Stock (APVO) Latest News
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - aberdeennews.com
Is Aptevo Therapeutics Inc. stock trending bullish2025 Top Decliners & Capital Efficient Trading Techniques - classian.co.kr
Can technical indicators confirm Aptevo Therapeutics Inc.’s reversalJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Automated trading signals detected on Aptevo Therapeutics Inc.Fed Meeting & Weekly Momentum Picks - Newser
Aptevo Therapeutics Inc. stock daily chart insightsWeekly Market Report & Long Hold Capital Preservation Tips - Newser
Is Aptevo Therapeutics Inc. a speculative investmentJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک
Does Aptevo Therapeutics Inc. have a sustainable dividendJuly 2025 Price Swings & Comprehensive Market Scan Reports - خودرو بانک
Will Aptevo Therapeutics Inc. benefit from sector rotationJuly 2025 Weekly Recap & Daily Oversold Bounce Ideas - خودرو بانک
What is Aptevo Therapeutics Inc.’s book value per shareEarnings Trend Report & Reliable Breakout Stock Forecasts - خودرو بانک
Can Aptevo Therapeutics Inc. navigate macro headwindsTrade Entry Report & Daily Volume Surge Trade Alerts - خودرو بانک
Ranking Aptevo Therapeutics Inc. among high performing stocks via toolsPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Visual analytics tools that track Aptevo Therapeutics Inc. performance2025 Short Interest & Real-Time Volume Triggers - Newser
With New Cash Aptevo Goes It Alone on Prostate Drug, Shares UpBiotech Movers - TheStreet
What to do if you’re stuck in Aptevo Therapeutics Inc.Weekly Trade Summary & Low Drawdown Investment Strategies - Newser
News impact scoring models applied to Aptevo Therapeutics Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Aptevo Therapeutics unveils new trispecific immune cell engagers - BioWorld MedTech
How institutional ownership impacts Aptevo Therapeutics Inc. stockMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser
Aptevo expands cancer pipeline with two new trispecific therapies By Investing.com - Investing.com Nigeria
Evaluating Aptevo Therapeutics Inc. with trendline analysisIPO Watch & Target Return Focused Picks - Newser
Aptevo Therapeutics Expands Anti-Cancer Pipeline with Patents - MSN
Is Aptevo Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Final Week & High Conviction Investment Ideas - khodrobank.com
Can Aptevo Therapeutics Inc. expand into new marketsMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک
Why Aptevo Therapeutics Inc. is moving todayRecession Risk & AI Based Trade Execution Alerts - Newser
What momentum shifts mean for Aptevo Therapeutics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
How cyclical is Aptevo Therapeutics Inc.’s revenue streamJuly 2025 Sector Moves & Fast Gaining Stock Reports - خودرو بانک
Aptevo expands cancer pipeline with two new trispecific therapies - Investing.com
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules - ACCESS Newswire
First-Ever Triple-Action Cancer Therapy: Aptevo's New Trispecifics Target Tumors 3 Ways at Once - Stock Titan
What is Aptevo Therapeutics Inc. s 5 year growth outlookMarket Movers & Verified Swing Trading Watchlists - خودرو بانک
Risk vs reward if holding onto Aptevo Therapeutics Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser
Real time social sentiment graph for Aptevo Therapeutics Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser
Can volume confirm reversal in Aptevo Therapeutics Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
Real time pattern detection on Aptevo Therapeutics Inc. stockEntry Point & Scalable Portfolio Growth Ideas - Newser
Using data models to predict Aptevo Therapeutics Inc. stock movementJuly 2025 Sector Moves & Risk Controlled Stock Alerts - Newser
Is Aptevo Therapeutics Inc. a defensive stockJuly 2025 Price Swings & AI Driven Price Forecasts - خودرو بانک
How to manage a losing position in Aptevo Therapeutics Inc.Profit Target & Daily Technical Forecast Reports - Newser
How moving averages guide Aptevo Therapeutics Inc. trading2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Is Aptevo Therapeutics Inc. currently under institutional pressureJuly 2025 Earnings & Intraday High Probability Setup Alerts - خودرو بانک
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedGap Down & Real-Time Stock Entry Alerts - Newser
Will breakout in Aptevo Therapeutics Inc. lead to full recovery2025 Year in Review & Stock Timing and Entry Methods - Newser
Aptevo Therapeutics Inc Stock (APVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):